Haisco Pharmaceutical Group Co., Ltd. Haisco Pharmaceutical Group Co., Ltd.

Haisco Pharmaceutical Group Co., Ltd.

002653

Rank in Stocks #2095
Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates... Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates within China, focusing on the research, production, and distribution of a diverse range of pharmaceutical products. Their offerings span various dosage forms, including small and large volume injections, freeze-dried and conventional powder injections, and active pharmaceutical ingredients (APIs). These medications target numerous therapeutic areas such as anti-infectives, digestive system disorders, blood system conditions, nervous system ailments, parenteral nutrition, antibiotics, emergency care, anesthesiology, and oncology. Furthermore, the company provides drugs in tablet, capsule, granule, and ointment forms for cardiovascular health, infectious diseases, digestive issues, central nervous system (CNS) conditions, diabetes, and hepatic diseases. Established in 2000 and based in Shannan, China, the company adopted its current name, Haisco Pharmaceutical Group Co., Ltd., in March 2016, having previously been known as Xizang Haisco Pharmaceutical Group Co., Ltd.
Share Price
$8.93
Market Cap
$10.19B
Change (1 day)
3.39%
Change (1 year)
22.78%
Country
CN
Trade Haisco Pharmaceutical Group Co., Ltd. (002653)

Category

Healthcare
Stock split history for Haisco Pharmaceutical Group Co., Ltd. (002653)
Haisco Pharmaceutical Group Co., Ltd. stock (symbol: 002653) underwent a total of 2 stock splits.
The most recent stock split occurred on Sep 12, 2013.
One 002653 share bought prior to Mar 11, 2013 would equal to 2.7 002653 shares today.
Stock split list
Year Split Multiple Cumulative Multiple
2013-09-12 27:20 x1.35 x2.7
2013-03-11 2:1 x2 x2
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
US
1 x3
AU
0 -
CH
0 -
NL